"pancreatic cancer treatment" trang 2 - tải miễn phí từ tailieunhanh
Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: A systematic review

Exercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: A systematic review
17    22    1
A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma

A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma
17    2    1
HIV INFECTION IN THE ERA OF HIGHLY ACTIVE ANTIRETROVIRAL TREATMENT AND SOME OF ITS ASSOCIATED COMPLICATIONS

HIV INFECTION IN THE ERA OF HIGHLY ACTIVE ANTIRETROVIRAL TREATMENT AND SOME OF ITS ASSOCIATED COMPLICATIONS
222    56    0
Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma

Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma
5    74    0
Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer

Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer
12    44    1
Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells

Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells
7    13    1
CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
12    2    1
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells
12    44    1
Treatment with anticancer drugs for advanced pancreatic cancer: A systematic review

Treatment with anticancer drugs for advanced pancreatic cancer: A systematic review
16    1    1
CARCINOGENESIS, DIAGNOSIS, AND MOLECULAR TARGETED TREATMENT FOR NASOPHARYNGEAL CARCINOMA

CARCINOGENESIS, DIAGNOSIS, AND MOLECULAR TARGETED TREATMENT FOR NASOPHARYNGEAL CARCINOMA

256    81    0
MESOTHELIOMAS – YNONYMS AND DEFINITION, EPIDEMIOLOGY, ETIOLOGY, PATHOGENESIS, CYTO-HISTOPATHOLOGICAL ATURES, CLINIC, DIAGNOSIS, TREATMENT, PROGNOSIS

MESOTHELIOMAS – YNONYMS AND DEFINITION, EPIDEMIOLOGY, ETIOLOGY, PATHOGENESIS, CYTO-HISTOPATHOLOGICAL ATURES, CLINIC, DIAGNOSIS, TREATMENT, PROGNOSIS

256    84    0
Lyme disease: Diagnosis, treatment and referring

Lyme disease: Diagnosis, treatment and referring
5    49    0
Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: A prospective, phase II, multicentre, single-arm study
7    80    0
Study protocol for an open-label, singlearm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma

Study protocol for an open-label, singlearm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma
8    54    1
Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells

Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells
9    50    1
Classification prediction of pancreatic cystic neoplasms based on radiomics deep learning models

Classification prediction of pancreatic cystic neoplasms based on radiomics deep learning models
10    1    1
Successful treatment of gemcitabineinduced acute interstitial pneumonia with imatinib mesylate: A case report

Successful treatment of gemcitabineinduced acute interstitial pneumonia with imatinib mesylate: A case report
5    27    1
Clinical outcome of patients with pancreatic metastases from renal cell cancer

Clinical outcome of patients with pancreatic metastases from renal cell cancer
6    38    1
Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: A case report

Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: A case report
6    55    0
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles

Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles
13    46    1